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INTRODUCTION 
An animal faces many stresses throughout its life and even throughout the 
duration of a single day. Potential prey have to be ready to respond quickly to the 
surprise appearance of a predator. A predator may need to have the ability to exert the 
extra spurt of energy required to catch and kill its prey even under harsh environmental 
conditions. Animals must be able to allow for large energy bursts to avoid predators or 
catch prey, sometimes for extended durations or distances. In other cases, animals may 
have to adjust their normal homeostasis to deal with harsh environmental conditions. 
They need to be able to adjust energy expenditures to supply the muscles with extra 
energy during bursts, even in times of near starvation, or to conserve energy under harsh 
conditions. In still other instances, they may have to limit their attack on pathogens or 
parasites to avoid immune and inflammatory responses from leading to excessive tissue 
damage (Bamberger et al. 1996). In fact, Chrousos et al. (1992) suggest that " [human] 
physiological mechanisms for coping with adversity have not evolved appreciably over 
the past several thousand years" so that our "physiological responses to social pressures, 
information overload, and rapid change resemble those set into motion during physical 
danger and outright threats to survival." (Chrousos et al. 1992). 
Many facets of the neuroendocrine system are activated during the stress 2 
response. First, corticotropin-releasing factor (CRF) is released within the brain and from 
neurons in the median eminence of the hypothalamus. Within the hypothalamo-pituitary 
axis, the nerve terminals in the median eminence secrete CRF which is transported to 
corticotropes within the adenohypophysis. CRF stimulates the secretion of corticotropin 
(ACTH) and 0-endorphins. ACTH enters the general circulation and travels to the 
adrenal cortex (interrenal glands of amphibians, where it stimulates glucocorticoid 
secretion (mainly cortisol or corticosterone, depending on the species). The adrenal 
medulla also can be activated by stressful stimuli to secrete its hormones, epinephrine and 
norepinephrine. The stimulation of the adrenal medulla is controlled by neuronal 
pathways originating in the brain. CRF can also have direct actions in the brain, acting 
on specific target neurons within various brain regions known to respond to CRF. The 
large number of steps and pathways involved allows the body to fine-tune the stress 
response, since control can be exerted at any one of these steps. 
CRF is involved in many components of the stress response. CRF has 
hypophysiotropic actions to regulate release of ACTH and 0-endorphins and is secreted 
in response to intense physical or psychological stress (Merlo-Pich et al. 1993). Various 
stressors such as cold swim, physical restraint or ether inhalation in rats will cause an 
immediate release of CRF into the hypophysis and an increase in CRF synthesis in the 
paraventricular nucleus (PVN) (Chappell et al. 1986). Hypophysiotropic actions of CRF 
tend to be slow and typically elicit effects within hours or days of their onset. 
CRF also regulates functions directly in the brain, including modifiable and 3 
unlearned responses to stressors (Heinrichs et al. 1992). In response to various types of 
stressors (restraint, exercise, social defeat, or ethanol withdrawal) CRF can act directly in 
the brain to cause behaviors associated with stress. For example, microinjections of CRF, 
into the PVN, can enhance dose-dependent locomotor activity and "anxiogenic-like" 
effects in rats (Monnikes et al. 1992). Also in rats, intracerebroventricular (icy) 
administration produces dose-dependent behavioral activation of locomotor activity, 
rearing, and grooming (Sutton et al. 1982, Sherman and Kahn 1987). Administration of 
CRF antagonist during these tests blocks these behaviors, verifying that these actions are 
through CRF (Baldwin 1991; Heinrichs 1994). However, these behavioral effects of 
CRF are not blocked by hypophysectomy (Eaves et al. 1985) demonstrating that these 
actions are separate from hypophysiotropic actions. Neurotropic actions of CRF are 
typically rapid, occurring within seconds of CRF release or administration. 
There are several distinct populations of CRF neurons in the brain. Many distinct 
brain regions which are shown to possess CRF neurons do not show changes in CRF 
concentration in response to stressors (Chappell et al. 1986). However, the locus 
ceruleus, Barrington's nucleus and the olfactory bulb are specific brain regions which 
exhibit selective increases or decreases in CRF levels depending on the nature and 
duration of the stressor (Valentino et al. 1988; Imaki et al. 1991). In addition, CRF 
immunoreactivity has been show in the PVN, the central nucleus of the amygdala, the bed 
nucleus of the stria tenninalis, the substantia innominata, and the region of the locus 
ceruleus (Swanson et al 1983). The presence of CRF mRNA has been confirmed in most 4 
of these regions using in situ hybridization techniques (Sawchenko 1987). 
In roughskin newts (Taricha granulosa), CRF injection into the third ventricle of 
the brain has been shown to enhance locomotor activity (Moore et al. 1984, Lowry et al. 
1990). Locomotor activity has been shown increase in response to CRF in a dose-
dependent manner (Lowry et al. 1990). Hypophysectomy does not block these effects in 
newts so that, as in rats (Eaves et al. 1985), these CRF-induced behaviors appear to be 
independent of hypophysiotropic actions (Moore et al. 1984). 
Lowry developed experimental procedures with newts in order to investigate the 
neuroendocrine responses to harsh or threatening conditions. He developed a 
standardized handling procedure which can cause a fairly consistent increase in 
locomotor activity (Lowry et al. 1990) which I also used in my experiments. The 
increase in locomotor activity following exposure to the handling-stress procedure was 
demonstrated to be prevented by the CRF antagonist, a-helical CRF (Lowry and Moore 
1991). These results indicate that this handling-induced locomotion is a result of an 
increase in endogenous CRF in response to the stressor (Lowry & Moore 1991). 
Corticosteroids, a type of steroid hormones that is associated with the stress 
response, help in the maintenance of homeostasis as well as in controlling physiological 
and behavioral changes associated with stress. Basal levels of corticosteroids produce 
general permissive effects on the animal's physiology. Corticosteroids achieve this by 
regulating membrane permeabilities (including transport mechanisms) and also by 
regulating protein synthesis, creating new enzymes or receptors (Norris 1997). The 5 
permissive actions of corticosteroids have been shown to play a role in the action of the 
thyroid hormones, calcium-phosphorus balance, maintenance of muscle strength, glucose 
availability maintenance of normal functioning of the brain, maintenance of red blood 
cell formation, and many others (Asterita 1985, Norris 1997). 
At higher concentrations, for example at levels found in a stressed animal, 
corticosteroids cause physiological changes that help the animal prepare for and survive 
the immediate perceived or actual threat to its well-being. Corticosteroids also suppress 
excessive defense reactions which could prove more detrimental to the animal than the 
threat itself. The actions of corticosteroids are pleiotropic, affecting changes in 
carbohydrate and mineral metabolism, the immune system, cardiovascular system, as 
well as behavioral changes (de Kloet et al. 1994). 
Initially, under conditions of acute stress, corticosteroids decrease glucose uptake 
in some tissues, including adipocytes and some nerve cells. They also stimulate lipolysis 
in adipose tissue and the utilization of fats rather than glycogen and glucose for energy, 
thus conserving glucose and glycogen. Corticosteroids then begin to inhibit anabolism 
and promote catabolism of protein and catabolic effects on lymphoid, bone, connective 
and other body tissues. Through stabilization of lysosome breakdown and decrease in 
fibroblast activity, corticosteroids inhibit the inflammatory response. In addition, 
corticosteroids can prevent swelling by limiting the ability of white blood cells to reach 
the traumatized area and release more inflammatory substance with resultant loss of 
plasma to the tissues. 6 
Chronic stress, when associated with persistently high levels of glucocorticoids, 
can lead to similar actions to those caused by acute stress which may have different 
effects because of the extended nature of these actions or can lead to totally different 
actions from those caused by acute stress. Among other effects, chronic release of 
corticosteroids can severely weaken the muscular system. Constant high levels of 
corticosteroids also suppress lymphoid tissues throughout the body, reducing the overall 
level of immunity to almost all foreign substances (Asterita 1985). 
There is a wide range in the time course with which corticosteriods elicit their 
effects. In negative feedback actions of glucocorticoids, for example, there exist three 
phases: rapid feedback occurs within seconds to minutes of administration; intermediate 
feedback occurs within 2 - 10 hours; and delayed feedback occurs within days (Childs 
and Unabia 1990). Short-term effects of corticosterone have been demonstrated to inhibit 
CRF- and AVP-induced ACTH and (3- endorphin release (Jones and Hillhouse 1976, Liu 
et al. 1995 , Liu and Chen 1995), shorten the duration of ethanol-induced sleep in rats 
(Sze 1993), inhibit neuronal firing (Hua and Chen 1989, Rose et al. 1995) and inhibit 
sexual behaviors in newts (Moore and Miller 1985, Moore and Orchinik 1994). The 
long-term effects of chronically high concentrations of corticosterone have been shown to 
down regulate CRF receptors, inhibit CRF synthesis and release (Jones and Hillhouse 
1976), and affect alertness and behaviors such as the further enhancement of CRF-
enhanced acoustic startle reflex by corticosteroids which has been observed in rats (Lee et 
al. 1994). 7 
There appear to be two main types of receptors for mediating corticosteroid 
action. Typically, intracellular receptors regulate genomic actions, and membrane 
receptors regulate non-genomic actions. Membrane receptors for steroids are becoming 
more widely recognized, with increasing evidence for membrane receptors for 
progesterone (Alexander et al. 1996, Baldi et al. 1995), aldosterone (Urbach et al. 1996), 
estrogens (Farhat et al. 1996), androgens (Gorkzynska 1995), and corticosteroids 
(Orchinik et al 1991). 
There are two recognized types of intracellular corticosteroid receptors: type I 
and type II. Type I receptors are also called mineralocorticoid receptors because in 
mammals the naturally occurring ligand is the mineralocorticoid aldosterone. Type I 
receptors have high affinity for glucocorticoids and aldosterone (binding affinity: 
corticosterone = cortisol = aldosterone > dexamethasone: Kd  0.5 nM for corticosterone 
in rats) (Reul and de Kloet 1985). With such high affinity, a high percentage of type I 
receptors are occupied at basal, non-stress levels of corticosterone in rats. Type I 
receptors appear to be involved in tonic, nonselective actions involved in maintaining 
homeostasis in most tissues. Type I receptors in the kidney regulate sodium ion 
reabsorption by binding aldosterone selectively. The type II (glucocorticoid) receptor has 
a tenfold lower affinity for corticosteroids than type I receptors (binding affinity: 
dexamethasone > cortisol > corticosterone > aldosterone: Kd  2.5-5 nM for 
corticosterone values in rats). Therefore, in rats, the type II receptor is activated only 
during times when the animal has elevated levels of corticosteroids (Reul and de Kloet 8 
1985). In this way, the type II receptor is able to display phasic actions involved in 
regulation of stress responses. 
The traditional intracellular receptor model for steroid hormone actions involves 
gene transcription and protein synthesis as its mode of action. Because protein synthesis 
involves a number of time-consuming steps, intracellular receptor action usually requires 
a lag period of 20-30 minutes minimum and up to several hours or even days (Duval 
1983). Most research indicates that the genomic effects of corticosteroids are first 
observed after a period of hours or days. However, some effects of glucocorticoids which 
are dependent on protein synthesis have been reported to occur 15-20 minutes after 
administration (Hallahan et al. 1973). The more rapid actions of intracellular 
corticosteroid receptors may work by inhibiting protein synthesis so that the time 
required to elicit a physiological would depend on the rate of clearance of the protein 
from the particular system. 
Some of the best evidence that there are membrane receptors for glucocorticoids 
comes from work with newts (Orchinik et al. 1991). The corticosterone membrane 
receptor has been characterized for the roughskin newt and found to be 
pharmacologically distinguishable from the intracellular corticosteroid receptors 
(Orchinik et al. 1991). The rapid and reversible binding of corticosteroids to this receptor 
differs from the intracellular receptor in its affinities for specific ligands in amphibians 
(binding affinity for intracellular receptors in Xenopus laevis: dexamethasone > 
corticosterone: Ka = 9.03 nM for corticosterone [Lange & Hanke 1988] with comparable values found for Rana catesbeiana [Medhi et al. 1984]; binding affinity for membrane 
receptors in Taricha granulosa: CORT > cortisol > aldosterone >> dexamethasone: Kd 
0.5 nM [3H]CORT [Orchinik et al. 1991]). Dexamethasone (DEX) is a synthetic 
glucocorticoid which acts as an agonist for both type I and type II receptors. In contrast 
to the type II intracellular receptor, which has high affinity for DEX in rats (Kd = 6.2 nM, 
Anderson & Fanestil 1976) and in the clawed toad (Kd = 3.54 nM, Lange & Hanke 1988), 
the membrane receptor for CORT in newts does not bind DEX effectively (Orchinik et al. 
1991). This strong contrast between the intracellular and membrane receptor types 
conveniently allows experimenters to use DEX to distinguish between receptor types. 
In contrast to type I and type II receptors, the current model for membrane 
receptors is that they elicit very rapid effects; latencies range from minutes to 
milliseconds (Moore & Orchinik 1991). It is hypothesized, but not proven, that many of 
the rapid actions of corticosteroids are mediated by membrane receptors. For example, 
CRF and AVP-induced ACTH and 0-endorphin release, shortened duration of ethanol-
induced sleep, inhibition of neuronal firing have also been evidenced to be non-genomic 
and presumably membrane receptor mediated actions (Jones and Hillhouse 1976, Liu et 
al. 1995 , Liu and Chen 1995, Sze 1993, Hua and Chen 1989, Rose et al. 1995, Moore 
and Miller 1985, Moore and Orchinik 1994). 
In most cases, actions of corticosteroids have not been directly linked to a specific 
membrane receptor. However, data for the rapid suppression of sexual behaviors by 
CORT showed a strong correlation to binding of the characterized membrane receptor 10 
(Orchinik et al. 1991). The affinities of corticoids for [3H]CORT binding sites in 
synaptic membranes were shown to be linearly related to their potencies in rapid 
suppression of male reproductive behavior (Orchinik et al. 1991). 
In many cases, corticosteroids are documented to suppress the actions of CRF. 
Negative feedback on the hypophysiotropic actions of CRF attenuate the stress response 
by preventing continued ACTH release. In fast negative feedback on CRF in mammals, 
it has been suggested, but not demonstrated, that glucocorticoids act on a plasma 
membrane to affect the conformation of the CRF receptor and affect coupling to second 
messengers (Childs and Unabia 1990). Intermediate feedback effects are thought to 
involve rapidly synthesized protein which modify intracellular calcium signals (Antoni et 
al. 1992). Delayed feedback is also believed to be regulated by intracellular receptor 
regulation of ACTH release (Childs and Unabia 1990). 
Rose (1997) showed that CORT administration can suppress CRF-induced 
neuronal firing in newts. These data, however, showed that the direction of the effect 
(suppression or enhancement) of CORT on CRF-induced neuronal firing depends on the 
time sequence and order in which these two chemical messengers are administered. 
When CORT was injected 5 minutes before the CRF injection, or when it was injected 30 
minutes following the CRF injection, CRF-induced increase in neuronal activity was 
suppressed by CORT. However, if the CORT was injected 5-10 minutes after the CRF 
injection, there was a potentiation in neuronal activity. 
In summary, previous studies have shown that CRF can act centrally to enhance 11 
locomotor activity in animals exposed to harsh or stressful conditions. There also is 
evidence that many of the CRF actions are counteracted by elevated levels of 
glucocorticoids and that glucocorticoids can cause rapid behavioral responses by 
activating the membrane receptor for corticosteroids. Therefore, using roughskin newts, 
the present studies ask the following questions: (i) does CORT administration prevent 
stress-induced increases in locomotor activity? (ii) does CORT administration prevent 
CRF-induced increases in locomotor activity? (iii) does the time-course and 
pharmacological specificity of the effects of CORT on locomotor activity fit the model 
for intracellular or membrane receptors? 12 
EXPERIMENTAL METHODS 
Study Animals 
All experiments were performed on adult male roughskin newts (Taricha 
granulosa) which were on average 20 grams in mass and 18 cm in length. Newts were 
collected locally (Benton Co., OR) and held in the laboratory for three days prior to each 
experiment, by maintaining them in large holding tanks (85 cm in diameter) with flow-
through dechlorinated water at a depth of 28 cm. There were 30 to 60 newts in each 
holding tank. Newts were maintained and tested in an environmentally controlled room 
which had a photoperiod of 12L:12D with lights on at 7:00 and an ambient water 
temperature of 10 °C. All experiments were performed between the hours of 10:00 and 
16:00. Newts were returned to their original field site after completion of each 
experiment. 
Injection Procedures 
Intracerebroventricular injections into the third ventricle of the newt brain were 
given through a small hole made by a microdrill (Fine Science Tools, Inc.) through the 
top of the skull (Lowry 1991). The steel burr drill bit (Fine Science Tools, Inc.) was 
0.9 mm in diameter which allowed for a hole large enough for the insertion of a 
microinjection needle (glass tubing, 1.0 mm, World Precision Instruments, Inc., pulled to 
a fine point). A perfusion pump (Rainin Instrument Co., Inc.) was used to regulate the 
volume and flow rate for injecting solutions through the micropipet. Local anesthetic 13 
(Lanacane ®) was applied to the area of injection before and after the injection procedure. 
Each newt was injected approximately one minute after the other (duration of injection 
procedure). 
Ovine corticotropin-releasing factor (Bachem Biosource, Inc.) was dissolved in 
Amphibian Ringers (isotonic saline). The dosage of CRF was based on prior work by 
Lowry (1990) which showed that 25 ng was a submaximal dose which still resulted in 
significant increases in locomotor activity and that a 50 ng dose yielded the maximal 
effect. The stock solution of corticosterone (A4-pregnene-11(3, 21-dio1-3,20-dione) was 
prepared by dissolving CORT (Sigma Chemical Co.) in dimethyl sulfoxide (DMSO) 
(Fisher Chemical, Fisher Scientific) at a concentration of 20 nM. The stock solution was 
diluted to give a final injection concentration of 0.2 nmol CORT and 1% DMSO for 
Experiment 1 and 0.1 nmol CORT and 0.5% DMSO for experiments 2 and 3. 
Dexamethasone (9a -fluoro-16a -methyl prednisolone, DEX) (Sigma Chemical Co.) was 
prepared like CORT was, to produce a final concentration of 0.2 nmol DEX and 1% 
DMSO for Experiment 1 and 0.1 nmol and 0.5% for experiments 2 and 3. Vehicle 
injection solutions for both CORT and DEX consisted of 1% DMSO for experiment 1 
and 0.5% DMSO for experiments 2 and 3 dissolved in Amphibian Ringers. 
Testing Arena 
All experiments used a standard testing arena to measure locomotor activity. 
Locomotor activity in newts consists of combined swimming and walking movements 
underwater. Methods and behavioral testing apparatus were similar to those described by 14 
Lowry and Moore (1991). The testing arenas were made of opaque white plastic and had 
a height of 30 cm, an outside diameter of 25 cm, and an inside diameter of 7.5 cm. Each 
testing arena contained dechlorinated water to an approximate depth of 10 cm. Radial 
lines on the bottom surface of the arenas marked 8 equal sections and were used to 
measure locomotor activity. Final measurements were recorded as the number of line 
crossings per three minute interval. Each testing arena contained only one newt during 
experiments and data collection. 
25 
cm  cm 
Behavioral Tests 
Locomotor activity was recorded on video tape using an overhead camera to 
simultaneously monitor 20 testing arenas and a clock to record real time. Because only 
20 arenas could be monitored at one time by the camera, experiments were divided into 2 
to 4 time blocks. Each time block contained equal numbers of animals from all treatment 
groups (e.g. 5 animals from each of 4 treatment groups). Each experiment consisted of 
three to four blocks to yield sample sizes of between 15 to 20 newts per treatment group 
(60 to 80 newts in experiments with four treatment groups). 
Newts were allowed to walk and swim around freely in their arena for one hour 15 
while being video taped. Locomotor activity data were then collected from the video tape 
and recorded as the number of line crossings per 3 minute interval. For experiment 1, 
locomotor activity for each newt was recorded as the total number of line crossings for 
the three minutes immediately preceding handling stress and then for the three minutes 
immediately following handling stress. For experiments 2 and 3, the total number of line 
crossings per three minute interval was determined, starting at time zero (immediately 
after the injection and placement into the testing arena), for 7 or 10 consecutive 3-minute 
time intervals (a total of 21 or 30 minutes). Collecting the data in three minute intervals 
allowed for direct comparison of the locomotor activity of CRF-treated animals with 
values found in CRF experiments performed by Lowry (1990). 
Statistical Analysis 
Paired t-tests were used to analyze data from experiment 1, comparing locomotor 
activity during the 3 minutes before handling with the locomotor activity during the 3 
minutes following handling stress. To compare the effect of the corticosteroids on 
spontaneous activity (pre-handling levels) and on stress-induced activity (post-handling 
levels minus pre-handling levels) of vehicle-treated animals to steroid-treated animals in 
experiment 1 unpaired t-tests were used. For experiments 2 and 3, the total number of 
line crossings per 3 minute interval for intervals 3 through 7 (minutes 6-21) were 
averaged for each animal to calculate the mean number of line crossings per three 
minutes for each animal. Mean values in experiments 2 and 3 were analyzed using a two-
way ANOVA or a one-way ANOVA followed by Tukey HSD post-hoc test. 16 
RESULTS AND SPECIFIC METHODS 
Experiment 1 
Experiment 1 was designed to investigate the effects of CORT (or DEX) 
administration on locomotor activity before and after the animals were exposed to a 
standardized handling stress. Each animal was removed individually from the holding 
tank, given an icy injection, and then immediately placed into its own testing arena. In 
experiment 1A, newts received a single icy injection of CORT or vehicle (Fig. 1A). 
Experiment 1 A was performed on Dec 18, 1996 on newts collected on Dec 15. In 
experiment 1B, newts received a single icy injection of either DEX or vehicle (Fig 2A). 
Experiment 1B was performed on Dec 20 on newts collected Dec 17. Twenty minutes 
following the injection and 2 hours after the injection, each newt received a standardized 
handling stress for a duration of one minute. The handling-stress procedure consisted of 
holding the newt behind the forelimbs and atop the palm of the other hand while applying 
gentle pressure to the head with the thumb. This handling procedure was developed and 
described by Lowry and Moore (1991) and served to restrain rather than hurt the newt. 
Newts were subjected to the handling procedure at 20 minutes after the injection because 
it allowed ample time for the steroid to take effect but, most likely, not enough time for 
effects to result from protein synthesis. It also matched the time interval used by 
Orchinik et al. (1991) to investigate the rapid inhibitory effects of CORT on newt 
courtship behaviors. Locomotor activity for each newt was recorded for the 3 minutes 17 
Fig. 1 The effect of CORT administration on handling stress-induced locomotor activity 
of male roughskin newts. Animals received either vehicle of CORT icy injection. A. 
Experimental design. B. Statistical analysis and significant results. C. Handling stress 
applied 20 minutes after icy administration of CORT. Locomotor activity calculated as 
mean number of line crossings during the 3 minutes immediately preceding handling and 
for the 3 minutes following handling (mean ± SE). D. Difference in locomotor activity 
calculated as after handling minus before handling stress (mean ± SE) at 20 minutes post-
injection. E. Locomotor activity (mean ± SE) in response to handling stress applied 2 
hours after icy injection. F. Difference in locomotor activity calculated as after handling 
minus before handling stress (mean ± SE) at 2 hours post-injection. 18 
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B. Statistics 
Paired t-test Activity before vs. : vehicle at 20 min: t = 2.3, df = 23, p < 0.03; 
after handling*  : vehicle at 2 hr: t = 3.6, df =19, p < 0.002; 
: CORT at 2 hr: t = 4.1, df = 14, p < 0.001. 
Student's t-test Vehicle vs. CORT difference in activity** :  t = 2.4; df = 22; p < 0.02. 
20 min vs. 2 hr prehandling activity*** :  t = -2.2; df =14; p < 0.05. 
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A. Experimental design* 
vehicle  69 ng CORT 
handling stress at  n = 24  n = 24  *Injections were given in quantities 
20 min & 2 hr  of 1121. 
B. Statistics 
Paired t-test Activity before vs. : vehicle at 20 mill: t = 2.3, df = 23, p < 0.03; 
after handling*  : vehicle at 2 hr: t = 3.6, df =19, p < 0.002; 
: CORT at 2 hr: t = 4.1, df = 14, p < 0.001. 
Student's t-test Vehicle vs. CORT difference in activity** :  t = 2.4; df = 22; p < 0.02. 
20 min vs. 2 hr prehandling activity*** :  t = -2.2; df =14; p < 0.05. 
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Fig. 2 The effect of DEX administration on handling stress-induced locomotor activity 
of male roughskin newts Animals received either vehicle of DEX icy injection. A. 
Experimental design. B. Statistical analysis and significant results. C. Handling stress 
applied 20 minutes after icy administration of DEX. Locomotor activity calculated as 
mean number of line crossings during the 3 minutes immediately preceding handling and 
for the 3 minutes following handling (mean ± SE). D. Difference in locomotor activity 
calculated as after handling minus before handling stress (mean ± SE) at 20 minutes post-
injection. E. Locomotor activity (mean ± SE) in response to handling stress applied 2 
hours after icy injection. F. Difference in locomotor activity calculated as after handling 
minus before handling stress (mean ± SE) at 2 hours post-injection. 20 
A. Experimental design* 
vehicle  69 ng CORT 
handling stress at 
20 min & 2 hr 
n = 23  n = 23  *Injections were given in quantities 
of 1 IA 
B. Statistics 
Paired t-test Activity before vs. : vehicle at 20 min: t = 2.8; df = 19, p < 0.01; 
after handling* :DEX at 20 min: t = 2.9, df = 19, p < 0.01; 
: vehicle at 2 hr: t = 4.2, df = 19, p < 0.0005; 
: CORT at 2 hr: t = 4.1, df = 19, p < 0.0007. 
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before and the 3 minutes after the handling stress as the number of line crossings per 3-
minute interval. Data were collected from a video recording for the times mentioned 
above. 
Results are presented in Fig 1 and Fig 2. Experiment 1A revealed that a low dose 
of CORT, administered centrally, rapidly prevented the stress-induced increase in 
locomotor activity. Mean differences in locomotor activity (before and after handling) 
for CORT were significantly less than differences for vehicle at 20 minutes, but not at 2 
hours (Fig 1D & 1F). A paired t-test comparison of the activity levels before and after 
handling for CORT- and vehicle-treated newts showed a significant suppression of 
handling-induced locomotor activity by CORT at 20 minutes but not at 2 hours (Fig 1C 
& 1E). Handling-induced locomotor activity was significantly higher than pre-handling 
values in vehicle-treated animals at both times and in CORT-treated animals at 2 hours. 
In addition, pre-handling activity levels were significantly lower in CORT-treated 
animals at 2 hours in comparison to vehicle-treated newts. 
Mean differences in locomotor activity for DEX-injected newts, however, were 
not significantly different from the differences for vehicle-injected animals at 20 minutes 
or 2 hours (Fig 2D & 2F).  In addition, in response to the handling procedure, DEX-
treated newts showed significant increases in locomotor activity that were similar to and 
not statistically different from increases in vehicle-treated animals at both times tested 
(Fig 2C & 2E). 
These results show that the central administration of CORT, but not DEX, is 22 
capable of preventing handling-induced increases in locomotor activity as well as 
suppressing spontaneous locomotor activity. The decrease in spontaneous locomotor 
activity occurred only after 2 hours after CORT administration. The prevention of stress-
induced increases in locomotor activity, however, is rapid and transient: occurring 20 
minutes after the CORT injection but not at two hours after the injection. 
Experiment 2 
Experiment 2 was designed to investigate the effects of CORT (or DEX) 
administration on CRF-induced locomotor activity. Previous work indicated that the 
increased locomotor activity associated with the handling-stress procedure with newts 
involves endogenous CRF (Lowry 1991). Rose et al. (1997) also found that CORT can 
modify CRF-induced changes in neuronal activity.  Therefore, it seemed reasonable that 
the results from experiment 1 indicated that CORT may prevent CRF-induced increases 
in locomotor activity. 
As in experiment 1, each animal was removed individually from the holding tank, 
received one 2.0 IA icy injection containing one of the four treatments, and was then 
immediately placed into its own testing arena. In experiment 2A, to evaluate CORT, 
CRF interaction, newts received a single icy injection of vehicle, CORT, CRF, or CRF 
plus CORT (Fig 3A & 4A). Experiment 2A-1 was performed on Oct 11, 1996 on newts 
collected on Oct 8. Experiment 2A-2 was performed on Dec 11, 1996 on newts collected 
on Dec 8. In experiment 2B, which was performed on Feb 7 on newts collected on Feb 4, 
newts received an icy injection of vehicle, DEX, CRF, or CRF plus DEX (Fig 5A) to 23 
evaluate DEX x CRF interaction. 24 
Fig. 3 Effects of CORT on CRF-induced locomotor activity in male roughskin newts. 
Vehicle, CRF, CORT or CRF plus CORT administered in a single icy injection. A. 
Experimental design. B. Statistical analysis and results. C. Time course showing 
number of line crossings for the 30 minutes immediately following the icy injection 
divided into 10 consecutive 3-minute intervals. D. Mean locomotor activity per 3 minute 
interval calculated as the mean of the average of intervals 3 -7 (minutes 6 - 21) for each 
newt (mean ± SE). 25 
A. Experimental design*  B. Statistics 
vehicle  25 ng CRF  2-way ANOVA 
CRF main effect: 
vehicle  n= 15  n= 15  F(55,1) = 16.1; p < 0.001 
CORT main effect: 
F(55,1) = 2.95; p < 0.092 
69 ng CORT  n= 15  n= 15  CRF x CORT interaction: 
(0.2 nmol)  F(55,1) = 5.95; p < 0.018 
*Injections were given in quantities of 2 pl. 
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Fig. 4 Effects of CORT on CRF-induced locomotor activity in male roughskin newts. 
Vehicle, CRF, CORT, or CRF plus CORT administered in a single icy injection. A. 
Experimental design. B. Statistical analysis and results. C. Time course showing 
number of line crossings for the 21 minutes immediately following the icy injection 
divided into 7 consecutive 3-minute intervals. D. Mean locomotor activity per 3 minute 
interval calculated as the mean of the average of intervals 3 -7 (minutes 6 - 21) for each 
newt (mean ± SE). 27 
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CRF main effect: 
F(56,1) = 29.6; p < 0.001 
CORT main effect: 
F(56,1) = 1.69; p < 0.20 
CRF x CORT interaction: 
F(56,1) = 0.75; p < 0.39 
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Fig. 5 Effects of DEX on CRF-induced locomotor activity in male roughskin newts. 
Vehicle, CRF, DEX, or CRF plus DEX administered in a single icy injection. A. 
Experimental design. B. Statistical analysis and results. C. Time course showing 
number of line crossings for the 30 minutes immediately following the icy injection 
divided into 10 consecutive 3-minute intervals. D. Mean locomotor activity per 3 minute 
interval calculated as the mean of the average of intervals 3 -7 (minutes 6 - 21) for each 
newt (mean ± SE). 29 
A. Experimental design*  B. Statistics 
vehicle  25 ng CRF  2-way ANOVA 
CRF main effect: 
vehicle  n= 15  n= 15  F(56,1) = 2.54; p < 0.12 
DEX main effect: 
F(56,1) = 0.21; p < 0.65 
78 ng DEX  n= 15  n= 15  CRF x DEX interaction: 
(0.2 nmol)  F(56,1) = 0.43; p < 0.51 
*Injections were given in quantities of 2 ul. 
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Results from experiment 2 demonstrate that CORT administration has the ability to 
rapidly inhibit CRF responses. The exact nature and strength of this interaction, even the 
presence of any interaction at all, appears to be variable however. In experiments 2A-1 
and 2A-2, locomotor activity was significantly elevated in newts that received the CRF 
injection as indicated by significant F values for CRF main effect (Figs 3B & 4B). In 
experiment 2A-1, but not 2A-2, the CORT injection suppressed the CRF-induced 
increases in locomotor activity, as indicated by the significant F value for the CRF CORT 
interaction (Fig 3B). 
Experiment 2B was designed to investigate the specificity of the inhibitory effects 
of CORT, by testing the effects of DEX, which does not bind to the CORT membrane 
receptor. The results of experiment 2B, however, are inconclusive, because in this 
experiment CRF-injected newts showed an overall smaller increase in locomotor activity 
than previous experiments (Fig 5) and failed to show a significant elevation in locomotor 
activity in response to CRF. Therefore, the inhibitory effect of DEX administration on 
CRF-induced locomotion could not be assessed. 
Results of experiment 2 showed that CORT injection, in some cases, can 
significantly and rapidly suppress CRF-induced locomotor activity, but further 
experiments are necessary to determine if this effect is specific for CORT and not DEX. 
Experiment 3 
Experiment 3 was conducted on Apr 7 and 8, 1997, on newts which were 
collected on Apr 4 and 5, 1997. This experiment combined experiments 2A and 2B into 31 
one large experiment. Because the results of experiment 2B and a subsequent pilot study 
indicated that newts might be less responsive to CRF during this time of year, experiment 
3 used a higher dose (50 ng / Ill) of CRF than was used in experiment 2. Other 
procedures were identical to those for experiment 2, and newts received one of the 
following injections: vehicle, CORT, DEX, CRF plus CORT, or CRF plus DEX (Fig 
6A). Experiment 3 tested the effects of CORT and DEX on CRF-induced locomotion in 
one large experiment. 
Results from experiment 3 were similar to those of experiment 2B. Despite the 
higher dose of CRF, CRF injection failed to produce a significant increase in locomotor 
activity. Statistical analysis by a one-way ANOVA showed a significant overall effect, 
but the Tukey HSD post hoc test of the average revealed only one significant difference: a 
significant difference between DEX and CRF/DEX (Fig 6). 32 
Fig. 6 Effects of CORT or DEX on CRF-induced locomotor activity in male roughskin 
newts. Vehicle, CRF, CORT, CRF plus CORT, DEX, or CRF plus DEX administered in 
a single icy injection. A. Experimental design. B. Statistical analysis and significant 
results. C. Time course showing number of line crossings for the 30 minutes 
immediately following the icy injection divided into 10 consecutive 3-minute intervals. 
D. Mean locomotor activity per 3 minute interval calculated as the mean of the average 
of intervals 3 -7 (minutes 6 - 21) for each newt (mean ± SE). 33 
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DISCUSSION 
In experiment 1, exposure of control newts to the handling-stress procedure 
increased post-handling locomotor activity levels by approximately 83% above the pre-
handling levels of locomotor activity. In previous studies (Lowry and Moore 1991), the 
same handling-stress procedures produced an increase in locomotor activity in vehicle-
injected newts of approximately 180 % between pre- and post-handling levels.  Thus, in 
both studies the handling-stress resulted in significant increases in locomotor activity in 
roughskin newts, even though the magnitude of the responses were not the same. 
Results from experiment 1 demonstrated that CORT, but not DEX, can rapidly 
prevent the effects of handling-stress on locomotor activity. At 20 minutes, the handling-
induced increase in locomotor activity was prevented by CORT. Because DEX failed to 
cause the same response as CORT, and because CORT but not DEX binds to the 
membrane receptor (Orchinik et al. 1991), these results indicate that the rapid prevention 
of stress-induced increases in locomotor activity is specific, not common to all 
glucocorticoids, and may involve the membrane receptor. 
At 2 hours after the steroid injection in experiment 1, CORT no longer affected 
stress-induced increases in locomotor activity, demonstrating that this rapid effect of 
CORT is also transient, lasting less than 2 hours. CORT did, however, cause a decrease 
in spontaneous locomotor activity from that of vehicle-treated newts. DEX did not 
influence the effect of handling on locomotor activity 2 hours after the injection, nor did 35 
it significantly lower spontaneous locomotor activity. The absence of any effect of DEX 
on stress-induced increases in locomotor activity is consistent with the notion that 
intracellular type II receptors are not involved in these behavioral responses. Type II 
receptors have been shown to bind DEX with higher affinity than they bind CORT (Reul 
and de Kloet 1985, Orchinik et al. 1991). 
The temporary nature of CORT's effect in experiment 1 is probably caused by the 
small dose, which was most likely quickly diluted and cleared from the newt's system, 
causing only a short-term activation of the receptor mechanisms The dose of CORT that 
was injected (icy) was small (0.2 nmol = 69 ng): 20 times smaller than the ED50 (4 nmol) 
of CORT given ip for inhibiting clasping behavior in newts (Orchinik et al. 1991). 
Therefore, prevention of handling-induced increases in locomotor activity by CORT is 
rapid, specific, and transient. In addition, since rapid recovery of the system following 
steroid removal is considered characteristic of a non-genomic effect (Duval et al. 1983), 
these results suggest that this prevention by CORT is through non-genomic mechanisms. 
The rapidity and specificity of this CORT effect on locomotor activity suggests 
that this response is mediated through the membrane receptor that was characterized by 
Orchinik et al. (1991) in the roughskin newt. There is evidence that CORT membrane 
receptors exist in other vertebrate taxa. Towle and Sze (1983) demonstrated that there are 
specific binding sites for CORT in synaptic plasma membranes in rat brains. Hua and 
Chen (1989) provided further evidence for the existence of a membrane receptor by 
studying physiological responses in guinea pig ganglion neurons. In addition, the rapid 36 
inhibition of prolactin release by cortisol (a major corticosteroid in teleost fishes) in male 
Tilapia, has been suggested to work by "reducing the influx of extracellular Ca2+ through 
plasma membrane-associated Ca2+ channels" (Borski et al. 1991). 
Most evidence for membrane receptors comes from previous studies that 
document the rapidity of some of the actions of corticosteroids. Administration of 
various glucocorticoids has been shown to inhibit CRF-induced ACTH release (Antoni et 
al. 1992, Britton et al. 1986, Childs and Unabia, 1990, Dallman and Yates 1969, Hallahan 
et al. 1989, Hinz and Hirschelmann 1995, Jones et al. 1972, Widmaier and Daliman 
1984). Administration of glucocorticoids has also been demonstrated to affect neuronal 
firing within seconds to minutes (Rose et al. 1995, Ffrench-Mullen 1995, Orchinik et al. 
1994). The suppression of courtship behaviors by CORT in male roughskin newts was 
shown to occur within 8 minutes of an ip CORT injection (Orchinik et al. 1991). 
Neuronal firing in response to courtship behavioral stimuli was suppressed 10-15 minutes 
after CORT administration (Orchinik et al. 1994). In neurophysiological studies in 
newts, suppression of AVT- and CRF-stimulated medullary firing by CORT occurred 
within 1-5 minutes after ip administration of CORT (Rose et al. 1995). The rapidity of 
this response and others suggests that the interactions between CORT and CRF may 
involve non-genomic actions. 
There are differences in binding affinity and pharmacological specificity between 
the intracellular and membrane receptors for corticosteroids. Intracellular receptors bind 
both CORT and DEX with high affinity, and the type II receptor binds DEX with high 37 
affinity (Reul and de Kloet 1985, Orchinik et al. 1991). In contrast, the CORT 
membrane receptor in newts binds DEX with extremely low affinity (Orchinik et al. 
1991). This distinct difference in pharmacological signature between the intracellular and 
membrane receptors provides an experimental approach to distinguish between these two 
types of receptors. The work of Orchinik et al. (1991) provides an example where a 
specific behavioral response is associated with the membrane receptor for CORT. That 
study found a strong correlation between the binding affinities of various glucocorticoids 
(including CORT and DEX) to the CORT membrane receptor and the potency of these 
glucocorticoids to inhibit sex behaviors in newts within 20 minutes of the injection. The 
results from experiment 1, showing that CORT and not DEX suppresses handling-
induced locomotor activity at 20 minutes and that this effect no longer exists at 2 hours 
post-injection, is consistent with the hypothesis that these inhibitory effects of CORT are 
mediated by the membrane receptor. 
There is evidence that other systems, besides newt behaviors, may involve non-
genomic effects of CORT. Experiments on rat hypothalamic slices in vitro showed that 
corticosteroid administration can inhibit AVP release within 20 minutes in a dose 
dependent manner. This rapid effect of CORT is not affected by drugs that inhibit gene 
transcription, protein synthesis, or axoplasmic transport, indicating that this rapid effect is 
non-genomic (Liu et al. 1995, Liu and Chen 1995). Experiments by Sze (1993) showed 
that corticosteroid administered to rats 15 minutes before administration of a sleep-
inducing dose of ethanol significantly shortened the sleep time in a dose-dependent 38 
manner. Blood ethanol levels were the same across all treatments, demonstrating that the 
corticosteroids were not acting through a change in the metabolism of ethanol.  Also, 
corticosterone administered in a dose of 20 mg / kg reduced sleeping time from 33 
minutes to 14 minutes, showing that this is a rapid effect and so was interpreted as 
evidence for non-genomic mechanisms. Sandi et al. (1996) showed that corticosterone, at 
doses that mimic physiological concentrations of corticosterone in the plasma during 
periods of stress, induced an increase in locomotor activity in rats exposed to a novel 
environment; this response occurred within 7 5 minutes of the injection and was not 
suppressed by protein synthesis inhibitor nor by type I and type H receptor antagonists 
RU28318 and RU38486. 
Therefore, the CORT membrane receptor seems to be involved in many rapid 
physiological and behavioral effects in all vertebrates, based on studies in fish, 
amphibians, and mammals. Rapid behavioral effects have been demonstrated in Taricha 
as well. Arginine vasotocin, a neuropeptide which has been demonstrated to enhance 
sexual behaviors, can be rapidly inhibited by CORT as evidenced neurophysiologically 
by a decrease in neuronal firing in response to sexual stimuli (Rose 1995). 
Experiments 2 and 3 were conducted because it seemed likely that the action of 
CORT in the suppression of handling-induced locomotor behavior involved an 
interaction between CORT and CRF. In studies which showed that handling increases 
locomotor activity, Lowry (1991) showed that this increase in locomotor activity can be 
suppressed by an injection of the CRF antagonist, supporting the conclusion that 39 
endogenous CRF is responsible for the increase in locomotor activity when newts are 
exposed to the handling-stress procedure. Consistent with this conclusion, injection of 
CRF antagonist in mice reversed restraint-induced suppression of exploratory behavior 
(Berridge and Dunn 1987), providing another example of a CRF-mediated response to 
restraint stress. The inhibitory actions of CORT in experiment 1 suggested that CORT 
might be blocking either the release of CRF or its actions. 
Corticosteroids have been shown to rapidly modulate the effects of CRF in 
previous experiments in many species. The first report of a rapid effect of CORT was 
(Sayers and Sayers in 1947) was concerned with the negative feedback effects of CORT 
on CRF-stimulated ACTH release. The rapid phase of the negative feedback effects of 
glucocorticoids on ACTH secretion occurs within minutes of the administration of 
exogenous corticosteroids (Dallman and Yates 1969). In fact, rapid feedback has been 
demonstrated to occur within seconds to minutes in vivo and as early as within 10 
minutes in vitro (Widmaier and Dallman 1984). In newts, corticosterone administration 
can suppress neuronal firing within minutes of the CRF injection (Rose 1997). Thus, 
CORT has been shown to interact rapidly with CRF actions in different systems, and the 
effects of CORT on CRF actions are typically suppressive, but not always. 
Considering the above information, experiment 2 was designed to determine if 
CORT (or DEX) would rapidly modulate behavioral responses to exogenous CRF. 
Experiments 2A-1 and 2A-2 both revealed a significant effect of the CRF injection on 
locomotor activity (Figs 3 & 4). Mean locomotor activity was significantly higher in 40 
CRF-injected animals than in vehicle-injected animals. These results corresponded with 
the increase in locomotor activity found in previous studies in newts (Moore et al. 1984; 
Lowry et al. 1990; Lowry and Moore 1991). Similarly, CRF administration has been 
found to enhance locomotor activity in rats (Sutton et al. 1982; Veldhuis and De Wied, 
1984; Diamant and De Wied, 1991; Saunders and Thornhill, 1986; Sherman and Kahn, 
1987). 
Experiments 2A-1 and 2A-2 were intended to be replicate experiments testing the 
effect of CORT on CRF. CORT significantly suppressed the locomotor activity of the 
CRF-injected newts in experiment 2A-1 (Fig 3) but not experiment 2A-2. These results 
indicate that the ability of CORT to significantly suppress CRF-induced locomotor 
activity is variable. The difference in response could depend on unidentified differences 
in procedures, previous stress levels of the newts, or basal CORT levels. The reason for 
the inconsistent results in these experiments is unclear. 
It seems that the neuroendocrine mechanism controlling stress responses are 
extremely complex. There are large variations in individual newts' magnitude of 
behavioral responses to CRF injections, handling, control injections, and containment 
procedures (personal observations of Lowry and Chiavarini). Rose (1997) also found 
variation in the magnitude and the direction of the effect of CORT administration on 
CRF-induced medullary firings, depending on the sequence of the injections (which came 
first, CORT or CRF) and exact times at which the two chemical messengers were 
administered. Rose (1997) observed a potentiation of the CRF-induced firing when 41 
CORT was administered ip 5-10 minutes prior to CRF application, but a suppression of 
the response when CORT was administered even earlier than this or after CRF 
application. So, the inconsistency between experiments 2A-1 and 2A-2 may be a result 
of unidentified differences in the prior physiological state of the newts. 
Experiment 3 was designed to further investigate the effects of CORT on CRF. 
However, in experiment 3 CRF injection failed to produce a significant stimulation of 
locomotor activity (Fig 6), in contrast to experiments 2A-1 and 2A-2. Therefore, the 
results of experiment 3 did not provide any additional information about the interaction 
between CORT and CRF. 
Experiments 2B and 3 also were designed to investigate the effects of DEX on 
CRF-induced locomotor activity. Because the CRF injection in both of these 
experiments failed to cause significant behavioral effects, no conclusions could be drawn 
in terms of the effects of DEX on CRF-induced locomotion. Because of the lack of CRF 
effect, it remained undetermined whether DEX can rapidly modulate behavioral 
responses to CRF. 
Statistical analysis of experiment 3 indicated a significant difference between the 
CRF/DEX and the DEX treatment groups. This appeared to be a function of both a 
decrease in locomotor activity in the DEX treated animals and a potentiation of the CRF-
induced locomotor activity in the CRF/DEX group. The physiological significance and 
repeatability of this observation is unclear. If this is a repeatable effect, further studies 
will be required to determine the mechanisms behind these actions of DEX. 42 
One possible reason for the failure of CRF to elicit its effects was failure of 
physiologically active CRF to reach its site of action. Experiments 1 and 2 were 
performed with alliquots from the same stock solution, stored at 80 °C. Following the 
failure of CRF to enhance locomotor activity in experiment 2B, new CRF solution was 
made and two pilot experiments were performed to test the effects of CRF on locomotor 
activity in comparison to the effect of vehicle. These pilot experiments, like experiment 
2B, failed to show the effect of CRF on locomotor activity. 
The CRF dose which elicited the maximal response in dose-dependent studies by 
Lowry et al. (1990) was reported as 25 ng. However, balance calibration following these 
experiments revealed that the dose reported as 25 ng was actually 50 ng; thus, the dose of 
CRF which elicited a maximal response was in fact 50 ng (Lowry, personal 
communication). So, new CRF solution was made with a dose of 50 ng in 1 IA to 
determine if the dose which Lowry (1990) found to elicit the maximal CRF effect would 
cause significant increases in locomotor activity. Experiment 3 was performed with the 
50 ng dose solution and also failed to elicit a significant increase in locomotor activity. 
No other indicators of the biological activity could be tested to determine the 
physiological activity of the CRF at this time; but, to the best of our knowledge the lack 
of increase in locomotor activity in response to CRF was not a result of problems with the 
CRF. 
The experiments in which CRF failed to cause significant increases in locomotor 
activity were run in February and March, months which coincide with the newt breeding 43 
season. One possible reason for differences in the effects of CRF is that breeding males 
respond differently to the stress of capture and being kept in the laboratory in comparison 
to non-breeding males. In fact, previous studies of newts support this interpretation. 
Deviche et al. (1990) showed that when plasma CORT concentrations were determined 
for newts sampled in the field, the CORT levels of male newts did not change seasonally. 
Moore and Zoeller (1985), however, found that plasma CORT concentrations which were 
measured in newts that had been held in the laboratory for one day did change seasonally, 
with the highest plasma CORT concentrations occurring in males during the breeding 
season. These data suggest that male Taricha are more sensitive to the stress of capture 
during the breeding season than out of the breeding season. Therefore, all males in 
experiments 2B and 3 may have had elevated plasma CORT concentrations, due to the 
stress of capture, prior to any experimental treatments. 
So, there are several possible reasons for the failure of CRF to elicit the expected 
increase in locomotor activity. Technical problems could have caused these differences, 
though to the best of my knowledge this was not the case. Higher levels of CORT, of 
animals held in the laboratory during the breeding season, could prevent the CRF-induced 
increase in locomotor activity, as indicated by experiment 2A-1. In addition, endogenous 
opiates have been shown to prevent CRF-induce increases in locomotor activity and may 
be present in higher levels during the breeding season (Lowry et al. 1990). 
Results from these three experiments show that CORT, but not DEX, can rapidly 
suppress handling-induced locomotor activity. The rapidity, transiency, and specificity of 44 
this CORT effect suggests that this response is mediated through the membrane receptor 
that was characterized by Orchinik et al. (1991) in the roughskin newt. Results from 
these studies also indicate that CORT has the potential to rapidly suppress CRF-induced 
locomotor activity; this suppression is variable, however. In addition, the locomotor 
response to CRF appears to vary with the season. Because both experiments which 
involved DEX (experiment 2B & 3) failed to show significant increases in locomotor 
activity in response to CRF, no clear evidence in regards to possible rapid effects of DEX 
on CRF-induced locomotor activity could be demonstrated. Further studies are needed to 
verify the seasonal differences in response to stress, to clarify the reason for these 
differences, and also to clarify the role of DEX in rapid control of CRF-induced 
locomotor activity. 
These experiments demonstrate the extreme complexity of the stress response. 
Differences in the stress response probably depend on the physiological condition of the 
animal, its prior experience, and any number of other pre-existing factors. This makes 
sense since newts, like other animals, must respond to a number of different stressors: 
predators, sudden and severe changes in weather as well as changes in environmental 
conditions. So, in response to stress, a newt may need to change locations, stop moving, 
hide, or change other behaviors or aspects of their physiology. Therefore, the ability of 
corticosterone to rapidly effect stress-related behaviors is a small, but important part of a 
larger, more complex system. 45 
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APPENDICES  53 
Appendix A 
Background 
Neurophysiological data with roughskin newts show that the direction of the 
effect of CORT on CRF-induced neuronal firing depends on the time sequence and order 
in which CORT and CRF are administered (Rose 1997). Studies by Rose demonstrated 
that when CORT was given before CRF and when it was given 30 minutes following 
CRF administration, CRF-induced neuronal firing was suppressed. If the ip injection of 
CORT was administered 5 to 10 minutes after the CRF application, however, neuronal 
firing was potentiated (Rose 1997). 
Experiments A.la and A.lb 
Methods and Rationale 
This experiment was run in order to test if CORT given by ip injection five 
minutes after an icy injection of CRF icy would potentiate CRF-induced locomotor 
activity, as predicted by Rose's data described above. Newts first received an icy 
injection of 25.0 ng CRF or vehicle in a 1.0 ill injection. Five minutes later, each newt 
received an ip injection of either 25.0 µg CORT or vehicle in a 0.1 ml injection. Vehicle 
for both CRF and CORT was Amphibian Ringers. Experiment A.la was performed on 
July 9, 1996 on animals collected on July 6. Experiment A.lb was performed on July 31, 
1996 on animals collected on July 28. Locomotor activity was recorded as line crossings 
per three minute interval for 20 consecutive intervals for experiment A.1 a and for 7 54 
consecutive intervals for experiment A.1 b following the ip injection (see Methods pp. 10-
13 for general methods). 
Results and Discussion 
Although no significant interaction was observed, the trend seemed to be for 
CORT to potentiate CRF-induced locomotor effects (Fig AA a & A.1 b), consistent with 
the trend in neuronal firing found by Rose (1997). The locomotor activity induced by 
CRF, however, was lower than in experiments in which there was no ip injection (see Fig 
3 & 4 in the main body of text). It seems, then, that the ip injection confounds the data by 
adding an extra stressor. 55 
Fig. A.la Effects of CORT (ip) on CRF-induced locomotor activity in male roughskin 
newts. CORT given 5 minutes following CRF icy administration (replicate #1). A. 
Experimental design. B. Statistical analysis and results. C. Time course showing 
number of line crossings for the 2 hours immediately following the icy injection divided 
into 20 consecutive 3-minute intervals. D. Mean locomotor activity per 3 minute interval 
calculated as the mean of the average of intervals 3 -7 (minutes 6 - 21) for each newt 
(mean ± SE). 56 
A. Experimental design  B. Statistics 
vehicle  25 ng CRF  2-way ANOVA 
CRF main effect: 
vehicle  n = 15  n = 15  F(1, 55) = 26.9; p < 0.001 
CORT main effect: ID 
F(1, 55) = 0.052; p < 0.82 
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Fig. A.lb Effects of CORT (ip) on CRF-induced locomotor activity in male roughskin 
newts. CORT given 5 minutes following CRF icy administration (replicate #2). A. 
Experimental design. B. Statistical analysis and results. C. Time course showing 
number of line crossings for the 21 minutes immediately following the icy injection 
divided into 7 consecutive 3-minute intervals. D. Mean locomotor activity per 3 minute 
interval calculated as the mean of the average of intervals 3 -7 (minutes 6 - 21) for each 
newt (mean ± SE). 58 
A. Experimental design 
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Experiment A.2 
Methods and Rationale 
Experiment A.2 also aimed to test if behavioral effects of CORT ip and CRF icy 
administration would be consistent with CORT suppression of CRF-neuronal firing. This 
time, an ip injection of CORT was given 5 minutes following CRF administration. 
Newts first received an ip injection of either 25.0 pg CORT or vehicle in a 0.1 ml 
injection. Five minutes later, each newt received an icy injection of 25.0 ng CRF or 
vehicle in a 1.0 Id injection. Vehicle for both CRF and CORT was Amphibian Ringers. 
Experiment A1.2 was performed on September 23, 1996 on animals collected three days 
before on Sept 20. Locomotor activity was recorded as line crossings per three minute 
interval for 7 consecutive intervals following the ip injection (see Methods pp. 12-15 for 
general methods). 
Results and Discussion 
Again, the results were not significant. However, in contrast to 
neurophysiological data, CORT injection tended to affect CRF-induced responses in the 
direction of potentiation, rather than suppression of CRF-induced locomotor activity (Fig 
A.2). These results were also confounded by low locomotor activity levels in CRF-
treated newts. The line of study for experiments A.1 and A.2 was abandoned because of 
the inability to control for the confounding effects of the double injection procedure. 60 
Fig. A.2 Effects of CORT (ip) on CRF-induced locomotor activity in male roughskin 
newts. CORT given 5 minutes prior to CRF icy administration. A. Experimental design. 
B. Statistical analysis and results. C. Time course showing number of line crossings for 
the 21 minutes immediately following the icy injection divided into 7 consecutive 3-
minute intervals. D. Mean locomotor activity per 3 minute interval calculated as the 
mean of the average of intervals 3 -7 (minutes 6 - 21) for each newt (mean ± SE). 61 
A. Experimental design	  B. Statistics 
icv 
vehicle  25 ng CRF  2-way ANOVA 
CRF main effect: 
vehicle  n = 19  n = 19  F(1, 72) = 1.06; p < 0.31 
CORT main effect: 
F(1, 72) = 39.5; p < 0.001 
25 pg CORT	  n= 19  n= 19  CRF x CORT interaction: 
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Appendix B 
Background 
Serotonin concentrations have been shown to increase in the dorsomedial 
hypothalamus in response to either CRF or CORT administration in newts (Lowry 1995). 
The serotonin uptake inhibitor fluoxetine has been shown to greatly enhance CRF-
induced locomotor activity (Lowry et al. 1993). It was thought that the effect of CORT 
on serotonin might be reflected in pronounced changes in locomotor activity when newts 
receive combined treatment with fluoxetine 
Experiments B.1, B.2, and B.3 
Methods and Rationale 
CRF causes serotonin concentrations to increase in the dorsomedial hypothalamus 
and serotonin potentiates CRF-induced locomotor activity (Lowry 1995). Possible 
CORT and serotonin interaction effects on locomotor activity had not yet been 
investigated. Therefore, these experiments investigated the effects of CORT and 
fluoxetine on locomotor activity in roughskin newts. In experiment B.1, newts received 
either 100 ng fluoxetine or vehicle in a 1.0 gl icy injection (a pilot study group received 
100 ng of anandamide, a cannabinoid, in a 2 ill icy injection). Five minutes later, each 
newt received an ip injection of either 25.0 in CORT or vehicle in a 0.1 ml injection. 
Vehicle for both fluoxetine and CORT (as well as for anandamide) was Amphibian 
Ringers. This experiment was performed on Aug 12, 1996 on animals collected 3 days 63 
before on Aug 9. 
Experiment B.2 and B.3 were performed as dose-response experiment. In both 
experiment B.2 and in experiment B.3 all newts received a 1.0 ill icy injection of 100 ng 
fluoxetine. Five minutes later, each newt received an ip injection of either 0.0 pig, 3.114, 
6.2514, 12.5 1.1g, or 25.011g CORT in 0.1 ml Amphibians Ringers. This experiment was 
run on Aug 29, 1996 on newts collected three days before on Aug 26. In experiment 
A2.3 each newt received an ip injection of either 0.014, 25.0 pg, 50.0 pg, 100.0 µg, or 
200.0 µg CORT in 0.1 ml Amphibians Ringers five minutes after the icy of fluoxetine.  
This experiment was run on Sept 9, 1996 on newts collected three days before on Sept 6.  
Locomotor activity was recorded as line crossings per three minute interval for 7  
consecutive intervals following the ip injection (see Methods pp. 12-15 for general  
methods).  
Results and Discussion  
All three fluoxetine experiments failed to show any significant effect of fluoxetine 
or CORT administration on locomotor activity (Fig A2.1, A2.2, & A2.3). 64 
Fig. B.1 Effects of Fluoxetine (or Anandamide) (icy) and CORT (ip) on locomotor 
activity in male roughskin newts. A. Statistical analysis and results. B. Time course 
showing number of line crossings for the 21 minutes immediately following the icy 
injection divided into 7 consecutive 3-minute intervals. C. Mean locomotor activity per 
3 minute interval calculated as the mean of the average of intervals 3 -7 (minutes 6 - 21) 
for each newt (mean ± SE). 65 
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Fig. B.2 Effects of Fluoxetine (icy) and CORT (ip) on locomotor activity in male 
roughskin newts. A. Statistical analysis and results. B. Time course showing number of 
line crossings for the 21 minutes immediately following the icy injection divided into 7 
consecutive 3-minute intervals. C. Mean locomotor activity per 3 minute interval 
calculated as the mean of the average of intervals 3 -7 (minutes 6 - 21) for each newt 
(mean ± SE). 67 
A. Statistics 
One-way ANOVA 
F(4, 75) = 1.23; p < 0.304 
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Fig. B.3 Effects of Fluoxetine (icy) and CORT (ip) on locomotor activity in male 
roughskin newts. A. Statistical analysis and results. B. Time course showing number of 
line crossings for the 21 minutes immediately following the icy injection divided into 7 
consecutive 3-minute intervals. C. Mean locomotor activity per 3 minute interval 
calculated as the mean of the average of intervals 3 -7 (minutes 6 - 21) for each newt 
(mean ± SE). 69 
A. Statistics 
One-way ANOVA 
F(4, 75) = 1.39; p < 0.247 
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